ARCHIVES

FDA, CMS Take Second Look at Drugs Given “Accelerated” Approval for Cancer

This article is from The Cancer Letter archive.

Vol. 29 No. 12 | March 21, 2003

Download PDF Visit The Full Archive

Related Articles

ACS Medals Of Honor To Bonadonna, Hsu, Louis Sullivan

December 13, 1991

Pfizer’s Inlyta Gives FDA a Teaching Moment: Not All PFS Advantages Are Created Equal

December 16, 2011

Phase III Alimta Trial Fails To Extend Progression-Free Survival Without Grade 4 Adverse Events

June 28, 2013

Abstracts of Papers From ASCO Meeting

April 14, 1978

NCI-Approved Clinical Trials

November 24, 2006

NCI Letter To Pittsburgh Details Deficiencies In NSABP Operations

April 8, 1994